Volgen
Sinem Perk
Sinem Perk
Systems Scientist at Argonne National Laboratory
Geverifieerd e-mailadres voor anl.gov
Titel
Geciteerd door
Geciteerd door
Jaar
Collective and individual migration following the epithelial–mesenchymal transition
IY Wong, S Javaid, EA Wong, S Perk, DA Haber, M Toner, D Irimia
Nature materials 13 (11), 1063-1071, 2014
2002014
Association of anticholinergic burden with cognitive impairment and health care utilization among a diverse ambulatory older adult population
NL Campbell, AJ Perkins, P Bradt, S Perk, RC Wielage, MA Boustani, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (11 …, 2016
992016
A metabolic index of ischemic injury for perfusion-recovery of cadaveric rat livers
S Perk, ML Izamis, H Tolboom, B Uygun, F Berthiaume, ML Yarmush, ...
PLoS One 6 (12), e28518, 2011
502011
Monte Carlo sampling and principal component analysis of flux distributions yield topological and modular information on metabolic networks
B Sarıyar, S Perk, U Akman, A Hortaçsu
Journal of Theoretical Biology 242 (2), 389-400, 2006
332006
Statistical monitoring of complex chemical processes using agent-based systems
S Perk, F Teymour, A Cinar
Industrial & Engineering Chemistry Research 49 (11), 5080-5093, 2010
322010
Mirabegron for the treatment of overactive bladder: cost-effectiveness from US commercial health-plan and Medicare Advantage perspectives
RC Wielage, S Perk, NL Campbell, TM Klein, LM Posta, T Yuran, ...
Journal of Medical Economics 19 (12), 1135-1143, 2016
302016
A fitness index for transplantation of machine-perfused cadaveric rat livers
S Perk, ML Izamis, H Tolboom, B Uygun, ML Yarmush, K Uygun
BMC Research Notes 5, 1-7, 2012
282012
Adaptive agent-based system for process fault diagnosis
S Perk, F Teymour, A Cinar
Industrial & engineering chemistry research 50 (15), 9138-9155, 2011
222011
An adaptive fault‐tolerant control framework with agent‐based systems
S Perk, QM Shao, F Teymour, A Cinar
International Journal of Robust and Nonlinear Control 22 (1), 43-67, 2012
172012
Estimated budget impact of increased use of mirabegron, a novel treatment for overactive bladder
S Perk, RC Wielage, NL Campbell, TM Klein, A Perkins, LM Posta, ...
Journal of Managed Care & Specialty Pharmacy 22 (9), 1072-1084, 2016
132016
Identifying gaps in the photographic record of the vascular plant flora of the Americas
NCA Pitman, T Suwa, C Ulloa Ulloa, J Miller, J Solomon, J Philipp, ...
Nature plants 7 (8), 1010-1014, 2021
102021
Batch process monitoring using multiblock multiway principal component analysis
S Perk, A Çinar
IFAC Proceedings Volumes 39 (2), 209-214, 2006
92006
Methods and compositions for preserving tissues and organs
ML Yarmush, M Toner, ML Izamis, TA Berendsen, RM Bieganski, OB Usta, ...
US Patent 10,575,515, 2020
72020
Enhancing the budget impact model for institutional use: a tool with practical applications for the hospital oncology pharmacy
LM Hess, FN Cinfio, S Wetmore, C Churchill, C Fausel, A Ale-Ali, ...
Hospital Pharmacy 51 (6), 452-460, 2016
72016
Machine perfusion enhances hepatocyte isolation yields from ischemic livers
ML Izamis, S Perk, C Calhoun, K Uygun, ML Yarmush, F Berthiaume
Cryobiology 71 (2), 244-255, 2015
72015
Monitoring, Analysis and Diagnosis of Distributed Processes with Agent-Based Systems
S Perk, F Teymour, M North, E Tatara, M Altaweel
IFAC Proceedings Volumes 42 (11), 637-642, 2009
72009
Preliminary phenotypic characterization of newly isolated halophilic microorganisms by footprinting: a rapid metabolome analysis
B Sarıyar-Akbulut, A Salman-Dilgimen, S Ceylan, S Perk, AA Denizci, ...
Archives of microbiology 189, 19-26, 2008
72008
Cost-effectiveness of insulin glargine 300 units/ml (GLA-300) vs insulin degludec 100 units/ml (IDEG) IN T2D
D Murphy, X Yu, M Fournier, TM Klein, T Fan, S Perk, RON PREBLICK, ...
Diabetes 66 (Supplement 1), A354, 2017
42017
Agent-based monitoring, fault detection, diagnosis and control of spatially distributed processes
S Perk
IFAC Proceedings Volumes 40 (5), 285-290, 2007
32007
OP0162-HPR Estimating health-related quality of life for gout patients: a post-hoc analysis of utilities from the clear trials
F Pérez-Ruiz, A So, P Kandaswamy, R Karra, K Kelton, S Perk, T Bardin
Annals of the Rheumatic Diseases 77 (Suppl 2), 132-132, 2018
22018
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20